Wise, John Pierce
- University of Louisville · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,402
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#7,402
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wise, John Pierce as a PI. Multi-PI records show the full award amount for context.
- 5R35ES032876-03R35Contact PIChromosome Instability Drives Metal-Induced Lung CancerUniversity of Louisville · Pharmacology (NIH department code)$856.4Kaward amount
- 3R35ES032876-03S1R35Contact PIChromosome Instability Drives Metal-Induced Lung CancerUniversity of Louisville · Pharmacology (NIH department code)$355.7Kaward amount
- 3R35ES032876-03S2R35Contact PIChromosome Instability Drives Metal-Induced Lung CancerUniversity of Louisville · Pharmacology (NIH department code)$63.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Wise, John Pierce as a PI.
FY2023 award administered by University of Louisville (KY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardUniversity of Louisville
- 2010$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #9819
- 2021$5M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #4761